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Abstract
Following the introduction of percutaneous and endoscopic biliary drainage there has been an ongoing debate about the
indications and outcomes of endoscopic versus surgical drainage in a variety of bilio-pancreatic disorders. The evidence-
based literature concerning four different areas of pancreatobiliary diseases have been reviewed. Preoperative endoscopic
biliary drainage in patients with obstructive jaundice should not be used routinely but only in selected patients. For patients
with biliary leakage and bile duct strictures after a laparoscopic cholecystectomy, endoscopic stent therapy might be first
choice and surgery should be used for failures of endoscopic treatment. Surgery is the treatment of choice after transection
of the bile duct (the major bile duct injuries). The majority of patients with obstructive jaundice due to advanced pancreatic
cancer will undergo endoscopic drainage but for relatively fit patients with a prognosis of more than 6 months, surgical
drainage or even palliative resection might be considered. For patients with persistent pain due to chronic pancreatitis
surgical drainage combined with limited pancreatic head resection might be first choice for pain relief. Most importantly,
the management of patients with these pancreatobiliary diseases should be performed by a multidisciplinary HPB approach
and teamwork consisting of gastroenterologists, radiologists and surgeons.
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Introduction
Following the introduction of percutaneous and
endoscopic drainage techniques for the biliary tract
and more recently the pancreatic duct there has been
an ongoing debate worldwide regarding the indica-
tions for endoscopic/percutaneous versus surgical
drainage in a variety of bilio-pancreatic disorders.
Traditionally the AMC in Amsterdam had a very
active Department of Gastroenterology under the
leadership of Professor Guido Tytgat and Professor
Kees Huibregtse and excellent interventional radiol-
ogy under Professor Han Lame´ris, and therefore both
minimally invasive techniques and surgery were used
with good cooperation during the past decades.
This presidential lecture is an opportunity to review
the evidence-based literature concerning these differ-
ent drainage approaches for several HPB disorders
such as:
. obstructive jaundice and the role of preoperative
biliary drainage;
. endoscopic and surgical management of biliary
stricture and bile duct injury;
. endoscopic versus surgical palliative treatment of
pancreatic carcinoma; and finally,
. the use of both drainage procedures in patients
with chronic pancreatitis.
We should realize that the implementation of these
findings in daily HPB practice is mainly dependent on
the local expertise of the different partners in the
multidisciplinary HPB approach.
Obstructive jaundice and preoperative biliary
drainage
Surgery in patients with obstructive jaundice caused
by a periampullary (pancreas, papilla, distal bile duct)
tumor as well as a proximal bile duct tumor (Klatskin
tumor) is associated with a higher risk of postoperative
complications than in non-jaundiced patients. The
increased risk of surgery in jaundiced patients had
already been recognized in 1935 by Allen O. Whipple,
who proposed a two-stage procedure for surgery
in deeply jaundiced patients [1]. After the introduc-
tion of percutaneous and endoscopic drainage,
(Received 1 October 2007; accepted 4 October 2007)
ISSN 1365-182X print/ISSN 1477-2574 online # 2007 Taylor & Francis
DOI: 10.1080/13651820701729986
Correspondence: Prof. dr. Dirk J. Gouma, MD, Department of Surgery, Academic Medical Center, PO Box 22660, 1100 DD Amsterdam, The Netherlands.
Tel: 31 20 566 2166. Fax: 31 20 566 9243. E-mail: d.j.gouma@amc.nl
Presidential lecture: EHPBA, Verona 69 June 2007.
HPB, 2007; 9: 408413
ERCP/PTC and subsequent drainage was included in
the routine diagnostic work-up in several countries
[24].
Internal biliary drainage has been shown to improve
liver function and nutritional status, to reduce sys-
temic endotoxaemia and cytokine release, and subse-
quently to improve immune response in multiple
experimental models [59] (Table I). A number of
non-randomized studies on internal drainage reported
a reduced mortality and morbidity. However, other
clinical studies and small randomized trials could not
confirm the positive effect of preoperative biliary
drainage (PBD) on outcome [1012]. Some studies
even reported a deleterious effect, partly due to
complications associated with the drainage procedure
[4,13,14]. We found that around 90% of patients with
obstructive jaundice in The Netherlands currently
undergo preoperative drainage.
In the light of the ongoing controversy regarding
preoperative drainage, a meta-analysis of randomized
clinical trials and comparative studies was performed
[15]. No difference in mortality could be detected
between the two strategies, but the overall complica-
tion rate in patients who underwent preoperative
drainage was significantly higher compared with
direct surgical treatment, 57% and 42%, respectively.
Unfortunately, most of these studies have methodo-
logical flaws. A few studies used external (percuta-
neous) drainage only (no restoration enterohepatic
cycle), different tumors and levels of obstruction
(Klatskin tumors and pancreatic tumors) were in-
cluded, there was a wide range of drainage period
(from 10 to 32 days), and different types of operation
were compared (bypass vs resection). Therefore, a
prospective randomized trial addressing the effects of
PBD on patients with obstructive jaundice due to
distal obstruction is currently being performed as a
multicentre study in The Netherlands [16]. The study
design and protocol have been published and
210 patients should be included. An independent
safety committee recently analysed the data after
inclusion of 105 patients (50%). The treatment in
both arms pylorus-preserving pancreaticoduodenect-
omy (PPPD) (71% vs 64%) and bypass (30% vs 33%)
was not different. Mortality and complications rate in
both groups did not lead to early closure of the trial
and we are awaiting the final results. The outcome of
this study will probably have consequences for the
time interval for diagnostic work-up, the waiting time
for surgery and referral pattern.
The strategy for proximal lesions is even more
difficult. Most authors agree that at least extended
liver resection should not be performed in severely
jaundiced patients and they need drainage of the
‘remnant lobe’. The percutaneous or endoscopic
approach to these patients is still a matter of local
expertise and might be an important subject for a trial
for the future, because there are no data to compare
both techniques.
Endoscopic and surgical management of biliary
stricture and bile duct injury
Bile duct injury (BDI) after laparoscopic cholecys-
tectomy remains a major problem in current surgical
practice. BDI is associated with poor survival,
increased morbidity, and impaired quality of life
[17,18]. Timing of treatment and treatment strategy
in terms of a surgical reconstruction versus endo-
scopic and percutaneous drainage and dilatation
procedures are still subject to debate [19,20]. Man-
agement is of course partly dependent on the type of
injury [21].
According to the Amsterdam classification, type A
and B lesions (leakage of cystic duct and leakage of
the bile duct) will primarily be treated by endoscopy.
Type D lesions (transection of the bile duct) nearly
always need surgical reconstruction [19,2224].
Controversy still exists as to the management of type
C lesions (strictures) [2025]. Due to the nature of
the lesions, the unpredictable diagnostic work-up and
initial management in regional hospitals and variable
referral pattern, as well as different types of injury, a
randomized study might not be expected.
In a prospective cohort study 500 patients referred
to our centre were analysed in terms of internal
referral pattern and final treatment [26]. The referral
pattern of BDI patients from the initial hospital to the
tertiary center is summarized in Figure 1. The initial
referral rate to the Departments of Gastroenterology,
Surgery and Radiology was 66%, 29% and 5%,
respectively. The referral rate within the tertiary
centre, between different departments, ranged from
7% (from gastroenterology to radiology) to 40%
(from radiology to surgery). In all, 160 patients
(32%) underwent a definitive surgical treatment,
whereas endoscopy was the definitive treatment in
264 patients (53%) and a radiologic intervention in
58 patients (12%). Eighteen patients (4%) did
not receive additional interventional treatment after
referral.
Table I. The potential benefits and adverse effects of preoperative
biliary drainage in patients with obstructive jaundice.
. Potential benefit:
 Decreases bilirubin level/improves liver function
 Improves nutritional status/immune function
 Reduces endotoxaemia and TNF/IL-6 release
 Treatment of biliary infection (cholangitis)
 Assessment of intraductal extent of tumor (proximal
bile duct carcinoma)
. Adverse effects:
 Cholangitis (prolongs hospital stay)
 Morbidity of drainage procedure
 Secondary infection (postoperative) leading to
postoperative sepsis and leakage
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The hospital mortality was 0.4% (n2), and after a
mean follow-up period of 6.794.1 years, 42 patients
had died (8.4%), a relatively low mortality compared
with the study from Flum et al. [17]. In 10 of 42
patients who died, death was related to the biliary
injury.
Endoscopic stent therapy as a final treatment was
performed in 93 patients with persistent leakage of
the bile duct (including leakage of the cystic duct,
n67) and 110 patients underwent stenting for a bile
duct stricture [27]. The overall long-term success rate
(mean follow-up 4.5 years) was 95% for patients
with bile leakage and 74% for patients with strictures.
The mean duration of stents in situ was 2 months and
11.5 months, respectively (Table II). Independent
predictors for outcome were injuries classified as
Bismuth III and IV type, endoscopic stenting before
referral and the number of stents inserted at the first
procedure. We concluded that endoscopic stenting is
the treatment of first choice for these lesions. Surgery
is indicated after failure (6 months) of stenting.
As mentioned, surgical reconstruction by a hepati-
cojejunostomy has to be performed for nearly all type
D lesions as well as failures of endoscopic manage-
ment. Recently the long-term outcome of 151 patients
(mean follow-up 5.3 years) who underwent recon-
struction by a hepaticojejunostomy was analysed [28].
The in-hospital mortality was zero, surgical complica-
tions were found in 29 patients (19%) and 14 patients
(3%) developed a stricture at the anastomosis after a
mean follow-up period of 4.5 years.
In summary, reconstructive surgery has excellent
short-term as well as long-term outcome for patients
with major BDI (transection of the bile duct).
Endoscopic stenting is the primary treatment for
patients with bile leakage and strictures; surgery is
still indicated after failure of endoscopy.
Stenting versus bypass or resection as palliative
treatment of pancreatic carcinoma
Unfortunately the majority of patients with pancreatic
carcinoma will have palliative treatment and the
three most important symptoms that should be
treated in advanced pancreatic and periampullary
cancer are obstructive jaundice, duodenal obstruction
and pain. Biliary drainage can be achieved non-
surgically by placement of a biliary stent (endoscopi-
cally or percutaneously) or surgically by performing a
biliary bypass. The success rate for short-term relief
of biliary obstruction is comparable for both surgical
and non-surgical drainage procedures and varies
Table II. Endoscopic stent therapy in bile duct injury patients with biliary leakage and bile duct stricture.
Bile duct leakage Bile duct stricture
Parameter n93 % n110 %
Number of stent changes, median (range) 1 (05) 4 (012)
Mean duration of stents in situ, months (9SD) 2 (1.8) 11.5 (9.4)
Number of patients with a stent-related complication 12 13 36 33
Referred for surgery 1 1 22 20
Subsequent stenting for recurrence of stenosis 2 2 6 6
Mortality related to BDI 1 1 2 2
Successful endoscopic stenting 88 95 81 74
 Internal referral rates
Surgery n = 146
29%
Gastroenterology n = 329
66%
Radiology n = 25
5%
Surgery n = 160
32%
Gastroenterology n = 264
53%
Radiology n = 58
12%
 (22.6%)  (15.1%)  (18.8%)  (7.0 %)  (40.0%)
 (62.3%)
Department that performed the definitive treatment for BDI
Department to which BDI patients are referred
 (74.2%)  (60.0%)
Figure 1. Referral pattern of BDI patients within the AMC (adapted from Surgery 2007, 42).
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between 90 and 100%. Randomized studies (rela-
tively older studies performed between 1988 and
1994) comparing surgical biliary drainage and endo-
scopic drainage showed that surgical treatment is
associated with higher early morbidity, a longer
hospital stay and higher mortality, but long-term
results are better. Endoscopic treatment is associated
with more long-term complications such as cholangi-
tis, clotting of stents and gastic outlet obstruction
[2933].
In a more recent randomized study Nieveen et al.
compared a Wallstent versus a surgical bypass (hepa-
ticojejunostomy and gastroenterotomy) in patients
with pathology proven metastasis after a diagnostic
laparoscopy [34]. Survival and hospital-free survival
were longer after surgery compared with stenting
(192 days vs 116 days, respectively), but this was a
selected group of relatively fit patients. The new
development of duodenal stenting for gastric outlet
obstruction might change the indication for bypass
surgery [35].
Currently palliative resection is also performed in
a selected group of patients with limited liver or
peritoneal metastasis, and a recent study showed a
mean survival of 15 months and acceptable morbidity
and mortality [36]. These encouraging results of
palliative resection might also be due to a selection
bias. A well conducted controlled trial of the role of
palliative resection is still not available.
In summary, endoscopic treatment will still be
indicated in the majority of patients; however, surgical
palliation with a bypass procedure or even with a
palliative resection might be preferred in a selected
group of relatively fit patients.
Endoscopic and surgical drainage in chronic
pancreatitis
Management of pain in chronic pancreatitis, particu-
larly chronic pain, that is insufficiently relieved by
medication (requiring opiates) remains a therapeutic
dilemma.
In patients with ductal obstruction, as well as an
inflammatory mass of 4 cm, a combined resection
and drainage procedure is generally accepted [37,38].
In patients with obstruction and a stricture/stones in
the pancreatic duct but without an inflammatory mass
in the pancreatic head, endoscopic and surgical
drainage have both been used frequently [39].
Reviewing the endoscopic treatment and summar-
izing the results from the literature from 11 studies
with more than 30 patients (n2319), stenting is
associated with 74% complete or partial pain relief
(mean follow-up 40 months) and 11% proceeded to
surgery.
Surgical drainage by lateral pancreaticojejunostomy
summarizing 16 studies with more than 20 patients
(n889) is associated with 80% complete or partial
pain relief, after a mean follow-up period of 63
months, with a mortality of 1.1%.
Recently we conducted a randomized trial compar-
ing endoscopic and surgical drainage with respect to
the outcome of pain relief, morbidity, quality of life
and pancreatic function.
This study showed that patients who underwent
surgery, as compared with those who were treated
endoscopically, had lower Izbicki pain scores (25 vs
51, pB0.001) and better physical health summary
scores on the Medical Outcomes Study 36-Item
Short-Form General Health Survey questionnaire
(p0.003). At the end of follow-up, complete or
partial pain relief was achieved in 32% of patients
assigned to endoscopic drainage as compared
with 75% of patients assigned to surgical drainage
(p0.007). Patients receiving endoscopic treatment
required more procedures than did patients in the
surgery group [40]. The benefits of surgery were
demonstrated by more rapid, effective and sustained
pain relief (Figure 2). Even with more aggressive
endoscopic management patients will suffer pain
during the relatively long treatment period, as shown
in our study. This study led to comments about
the surgical and endoscopic treatment. We should
realize that surgical treatment was limited to drainage
of the duct and not the pancreatic head area and the
uncinate process. Indeed four randomized studies
comparing different and more extended drainage
procedures with limited resection or standard PPPD
showed further improved results after more extended
treatment up to pain relief between 94% and 100%
[4144] (Table III). However, during the trial we were
limited to drainage by pancreaticojejunostomy instead
of the more commonly used Frey procedure that we
are using routinely after closing the trial.
This study was also led to comments about the
drawbacks of the endoscopic treatment in the trial,
such as the relatively short period of endoscopic
stenting [45].
Figure 2. Endoscopic versus surgical PD duct drainage: mean
Izbicki pain score during follow-up. (Adapted from NEJM, 2007;
356)
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Fortunately M. Delhaye and J. Devie`re, who also
performed the lithotripsy in our patients (n16)
recently published another randomized trial [46].
An even less invasive treatment protocol than
ours (ESWL only) showed that ESWL was superior
in terms of symptom relief and costs to prolonged
and aggressive stenting combined with ESWL. They
concluded that adding endoscopy and stenting on top
of ESWL adds to the costs of care without improving
outcome.
In the light of the results from that study the
criticism of our trial should be reconsidered [45].
We therefore conclude that surgery in patients
with advanced symptomatic chronic pancreatitis is
more effective than endoscopic treatment. Pain relief
is immediate and consistent. Combined surgical drai-
nage with limited pancreatic head resection might
further improve results in the near future.
Conclusions
Summarizing the role of endosopic versus surgical
drainage in four different areas of pancreatobiliary
disorders it can be concluded that preoperative
endoscopic intervention (preoperative biliary drai-
nage) in patients with obstructive jaundice should
not be used routinely but only in selected patients. For
patients with biliary leakage and bile duct strictures
after a laparoscopic cholecystectomy endoscopic stent
therapy might be first choice and surgery should be
used for failures and is the treatment of choice after
transection of the bile duct (the major bile duct
injuries).
The majority of patients with obstructive jaundice
due to advanced pancreatic cancer will undergo
endoscopic drainage, but for relatively fit patients
with a prognosis of more than 6 months survival,
surgical drainage or even palliative resection might
be considered. For patients with persistent pain due
to chronic pancreatitis, surgical drainage combined
with limited pancreatic head resection might be the
first choice for pain relief. Most importantly, manage-
ment of patients with these bilio-pancreatic disorders
should be performed by a multidisciplinary HPB
approach and teamwork consisting of gastroenterolo-
gist, radiologists and surgeons.
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